受容能開発因子の英語

癌治療に対するより有効な治療戦略の開発のために、感受性の増加と副作用の減少を伴う肝細胞増殖因子受容体（ＨＧＦＲ）拮抗剤の同定を可能にする手段を提供する。例文帳に追加

To provide a means for enabling identification of a hepatocyte growth factor receptor (HGFR) antagonist accompanied by increase of sensitivity and reduction of adverse effects to develop therapeutic strategy effective for cancer therapy. - 特許庁

ＮＲ１０は生体免疫調節、造血細胞調節に関与する新規なヘモポエチン受容体分子であり、同受容体と機能結合し得る新規造血性因子の検索や、免疫・造血系関連疾患の治療薬の開発に有用である。例文帳に追加

NR10 is a new hemopoietin receptor molecule participating in immunoregulation and hematopoietic cell regulation in vivo and is useful in searching a new hematopoietic factor functionally binding to the receptor and developing remedies for diseases concerning immune/hematopoietic systems. - 特許庁

ＮＲ１０は生体免疫調節、造血細胞調節に関与する新規なヘモポエチン受容体分子であり、同受容体と機能結合し得る新規造血性因子の検索や、免疫・造血系関連疾患の治療薬の開発に有用である。例文帳に追加

NR10 is a new hemopoietin receptor molecule implicated in the regulation of the immune system and hematopoiesis in vivo and useful in screening for new hematopoietic factors capable of functionally binding to the receptor, or developing medicines to treat diseases related with the immune system or hematopoietic system. - 特許庁

ＮＲ１０は生体免疫調節、造血細胞調節に関与する新規なヘモポエチン受容体分子であり、同受容体と機能結合し得る新規造血性因子の検索や、免疫・造血系関連疾患の治療薬の開発に有用である。例文帳に追加

NR10 is a new hemopoietin receptor molecule participating in the regulation of the immune system and hematopoiesis in vivo, and is useful for screening new hematopoietic factors capable of functionally binding to the receptor, or developing medicines to treat diseases related with the immune system or hematopoietic system. - 特許庁